News
Project provides ‘unprecedented understanding’ of cancers
Through extensive analyses of data from The Cancer Genome Atlas (TCGA), researchers have produced a new resource known as the Pan-Cancer Atlas....
News
Injectable hydrogels stop bleeding, promote healing
Biomedical engineers have developed hydrogels that can act as an “injectable bandage,” according to preclinical research published in Acta...
News
At-home measurement of WBCs
A portable device could be used to monitor patients’ white blood cell (WBC) levels at home, without the need for blood samples, according to...
News
How RBCs maintain their shape
New research indicates that non-muscle myosin II-A (NMIIA) plays a key role in maintaining red blood cell (RBC) shape and deformability....
News
Screening may reduce prevalence of MM
Targeted screening could potentially reduce the prevalence of multiple myeloma (MM), according to research published in JCO Clinical Cancer...
News
Drug receives priority review for HCL
The US Food and Drug Administration (FDA) has accepted for priority review the biologics license application (BLA) for moxetumomab pasudotox, an...
News
Agent exhibits activity in leukemias, MDS
The experimental agent prexigebersen (formerly BP1001) was considered well-tolerated and demonstrated early evidence of activity against relapsed/...
News
EC expands indication for denosumab to MM
The European Commission (EC) has approved an expanded indication for denosumab (Xgeva). The drug is now approved for the prevention of skeletal-...
News
Drug nets orphan designation for SCD
The European Commission (EC) has granted orphan designation to Altemia (formerly SC411) for the treatment of pediatric patients with sickle cell...
News
Test for HIT receives CE mark
HIT Confirm, a test used to diagnose heparin-induced thrombocytopenia (HIT), has received the CE mark. This means the test meets regulatory...
News
Team uses CRISPR to turn on fetal hemoglobin
Researchers have used CRISPR-Cas9 gene editing to reproduce naturally occurring mutations that boost the production of fetal hemoglobin. The...
News
FDA approves blinatumomab to treat MRD+ BCP-ALL
The US Food and Drug Administration (FDA) has expanded the approved indication for blinatumomab (Blincyto®). The drug is now approved to treat...
News
Drug receives orphan designation for AML
The US Food and Drug Administration (FDA) has granted orphan designation to MAX-40279 for the treatment of acute myeloid leukemia (AML). MAX-...
News
Disease, genetics contribute to neurocognitive decline in ALL
Chemotherapeutic agents have been associated with neurocognitive side effects in survivors of pediatric acute lymphoblastic leukemia (ALL). Now,...
News
Drug approved to treat all adults with iron deficiency
The European Commission (EC) has extended the approved indication of ferric maltol (Feraccru) to include treatment of all adults with iron...